Joacim Elmén, M. Lindow, Sylvia Schütz, M. Lawrence, A. Petri, S. Obad, M. Lindholm, Maj Hedtjärn, H. Hansen, U. Berger, S. Gullans, P. Kearney, P. Sarnow, E. Straarup, S. Kauppinen (2008)
LNA-mediated microRNA silencing in non-human primatesNature, 452
Joacim Elmén, M. Lindow, A. Silahtaroglu, M. Bak, M. Christensen, A. Lind-Thomsen, Maj Hedtjärn, J. Hansen, H. Hansen, E. Straarup, Keith McCullagh, P. Kearney, S. Kauppinen (2007)
Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liverNucleic Acids Research, 36
J. Feld, S. Nanda, Ying Huang, WeiPing Chen, M. Cam, Susan Pusek, Lisa Schweigler, D. Theodore, S. Zacks, T. Liang, M. Fried (2007)
Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment responseHepatology, 46
M. Sarasin-Filipowicz, E. Oakeley, F. Duong, V. Christen, L. Terracciano, W. Filipowicz, M. Heim (2008)
Interferon signaling and treatment outcome in chronic hepatitis CProceedings of the National Academy of Sciences, 105
Lee for excellent technical assistance
R. Lanford, B. Guerra, Helen Lee, D. Chavez, K. Brasky, Catherine Bigger (2006)
Genomic response to interferon‐α in chimpanzees: Implications of rapid downregulation for hepatitis C kineticsHepatology, 43
Supporting Online Material www
G. Randall, M. Panis, J. Cooper, T. Tellinghuisen, K. Sukhodolets, S. Pfeffer, M. Landthaler, P. Landgraf, S. Kan, B. Lindenbach, Minchen Chien, David Weir, J. Russo, J. Ju, M. Brownstein, R. Sheridan, C. Sander, M. Zavolan, T. Tuschl, C. Rice (2007)
Cellular cofactors affecting hepatitis C virus infection and replicationProceedings of the National Academy of Sciences, 104
(2006)
DITTO-HCV Study Group
J. Feld, J. Hoofnagle (2005)
Mechanism of action of interferon and ribavirin in treatment of hepatitis CNature, 436
C. Jopling, Sylvia Schütz, P. Sarnow (2008)
Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome.Cell host & microbe, 4 1
David Butera, Svetlana Marukian, Amy Iwamaye, E. Hembrador, T. Chambers, A. Bisceglie, E. Charles, A. Talal, I. Jacobson, C. Rice, L. Dustin (2005)
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C.Blood, 106 4
M. Sarasin-Filipowicz, J. Krol, Ilona Markiewicz, M. Heim, W. Filipowicz (2009)
Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapyNature Medicine, 15
C. Chen, Yupeng He, L. Lu, H. Lim, R. Tripathi, T. Middleton, L. Hernandez, D. Beno, M. Long, W. Kati, Todd Bosse, D. Larson, R. Wagner, R. Lanford, W. Kohlbrenner, D. Kempf, T. Pilot-matias, A. Molla (2007)
Activity of a Potent Hepatitis C Virus Polymerase Inhibitor in the Chimpanzee ModelAntimicrobial Agents and Chemotherapy, 51
A. Romero, M. Lagging, J. Westin, A. Dhillon, L. Dustin, J. Pawlotsky, A. Neumann, C. Ferrari, G. Missale, B. Haagmans, S. Schalm, S. Zeuzem, F. Negro, Elke Verheij-Hart, K. Hellstrand (2006)
Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection.The Journal of infectious diseases, 194 7
R. Lanford, B. Guerra, Catherine Bigger, Helen Lee, D. Chavez, K. Brasky (2007)
Lack of response to exogenous interferon‐α in the liver of chimpanzees chronically infected with hepatitis C virusHepatology, 46
Limin Chen, I. Borozan, J. Feld, Jing Sun, L. Tannis, Catalina Coltescu, J. Heathcote, A. Edwards, I. McGilvray (2005)
Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection.Gastroenterology, 128 5
M. Diago, G. Castellano, J. García-Samaniego, C. Pérez, I. Fernández, M. Romero, O. Iacono, C. García-Monzón (2005)
Association of pretreatment serum interferon γ inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis CGut, 55
Brasky for veterinary support
M. Lagging, A. Romero, J. Westin, G. Norkrans, A. Dhillon, J. Pawlotsky, S. Zeuzem, M. Wagner, F. Negro, S. Schalm, B. Haagmans, C. Ferrari, G. Missale, A. Neumann, Elke Verheij-Hart, K. Hellstrand (2006)
IP‐10 predicts viral response and therapeutic outcome in difficult‐to‐treat patients with HCV genotype 1 infectionHepatology, 44
This work was supported by the Deutsche Forschungsgemeinschaft (grant KI 806/5-1) and the VolkswagenStiftung. We thank U. Merkel for contributing substantially to the reef occurrence data
C. Jopling, M. Yi, Alissa Lancaster, S. Lemon, P. Sarnow (2005)
Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNAScience, 309
F. Chisari (2005)
Unscrambling hepatitis C virus–host interactionsNature, 436
Catherine Bigger, B. Guerra, K. Brasky, G. Hubbard, M. Beard, B. Luxon, S. Lemon, R. Lanford (2004)
Intrahepatic Gene Expression during Chronic Hepatitis C Virus Infection in ChimpanzeesJournal of Virology, 78
Science – Unpaywall
Published: Dec 4, 2009
Access the full text.
Sign up today, get DeepDyve free for 14 days.